HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
Updated status and communication |
||
| Line 1,495: | Line 1,495: | ||
|- | |- | ||
|[[HAEM5:Hairy cell leukaemia|Hairy cell leukaemia]]||Disease||Pending Michael Lack, MD, KUMC | |[[HAEM5:Hairy cell leukaemia|Hairy cell leukaemia]]||Disease||Pending Michael Lack, MD, KUMC | ||
| || || || ||SG|| || | | || || || ||SG|| ||Need new author to update latest content. Prior author cannot update the page. | ||
|Hairy Cell Leukemia | |Hairy Cell Leukemia | ||
|Snehal Patel, MD, PhD | |Snehal Patel, MD, PhD | ||
| Line 1,503: | Line 1,503: | ||
|- | |- | ||
|[[HAEM5:Splenic marginal zone lymphoma|Splenic marginal zone lymphoma]]||Disease|| | |[[HAEM5:Splenic marginal zone lymphoma|Splenic marginal zone lymphoma]]||Disease|| | ||
| || || || ||SG|| || | | || || || ||SG|| ||Need new author to update latest content. Prior author cannot update the page. | ||
|Splenic Marginal Zone Lymphoma | |Splenic Marginal Zone Lymphoma | ||
|Snehal Patel, MD, PhD | |Snehal Patel, MD, PhD | ||
| Line 1,511: | Line 1,511: | ||
|- | |- | ||
|[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease|| | |[[HAEM5:Splenic diffuse red pulp small B-cell lymphoma|Splenic diffuse red pulp small B-cell lymphoma]]||Disease|| | ||
| || || || ||SG|| || | | || || || ||SG|| ||Need new author to update latest content. Prior author cannot update the page. | ||
|Splenic Diffuse Red Pulp Small B-cell Lymphoma | |Splenic Diffuse Red Pulp Small B-cell Lymphoma | ||
|Snehal Patel, MD, PhD | |Snehal Patel, MD, PhD | ||
| Line 1,527: | Line 1,527: | ||
|SG | |SG | ||
| | | | ||
| | |Need new author to update latest content. Prior author cannot update the page. | ||
|Hairy Cell Leukemia Variant | |Hairy Cell Leukemia Variant | ||
|Snehal Patel, MD, PhD | |Snehal Patel, MD, PhD | ||
| Line 1,543: | Line 1,543: | ||
|SG | |SG | ||
| | | | ||
| | |Email sent to request to update 2024 | ||
|(1) Lymphoplasmacytic Lymphoma + (2) Waldenstrom Macroglobulinemia | |(1) Lymphoplasmacytic Lymphoma + (2) Waldenstrom Macroglobulinemia | ||
|(1 and 2) Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | |(1 and 2) Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | ||
| Line 1,559: | Line 1,559: | ||
|SG | |SG | ||
| | | | ||
| | |Email sent to request to update 2024 | ||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) | ||
|Whayoung Lee, MD (trainee), Fabiola Quintero-Rivera, MD, FACMG* | |Whayoung Lee, MD (trainee), Fabiola Quintero-Rivera, MD, FACMG* | ||
| Line 1,609: | Line 1,609: | ||
|SG | |SG | ||
| | | | ||
| | |Need new author to update latest content. Prior authors cannot update the page. | ||
|Paediatric Nodal Marginal Zone Lymphoma | |Paediatric Nodal Marginal Zone Lymphoma | ||
|* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | |* Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | ||
|Complete | |Complete; Need new author to update latest content. Primary author cannot update the page. | ||
|11/11/2020 | |11/11/2020 | ||
| | | | ||
| Line 1,657: | Line 1,657: | ||
|SG | |SG | ||
| | | | ||
| | |Need new author to update latest content. Prior authors cannot update the page. | ||
|Paediatric-Type Follicular Lymphoma | |Paediatric-Type Follicular Lymphoma | ||
|*Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG | |*Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG | ||
|Complete | |Complete; Need new author to update latest content. Primary author cannot update the page. | ||
|8/16/2020 | |8/16/2020 | ||
| | | | ||